These results, together with a former report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two support the idea of concentrating on ACKR3 as a novel approach to modulate the opioid program, which could open new therapeutic avenues for opioid-similar Problems.May support ease nerve discomfort and